Against hypoglycemic seizures from insulin overdose, BPC-157 prevented brain lesions in cerebral cortex and hippocampus while simultaneously protecting the gut and liver, demonstrating unified cytoprotection
This makes it a highly targeted tool for metabolic research
Some muscle loss is inevitable Any patient with a restricted diet and poor nutrition/protein will have a drop in muscle mass
Tang W, Black AS, Moench R, Marzban K, Garay JAR, Zheng JJ, et al
In rat models, BPC-157 has been reported to accelerate tendon-to-bone healing and to reduce gastric ulcer surface area by as much as 78% in some experiments
If you: Have contraindications or complex medical needs requiring in-person care Strongly prefer FDA-approved medications and can access them affordably Want comprehensive support beyond medication (nutrition counseling, behavioral therapy, etc.) Are uncomfortable with the regulatory uncertainty around compounded GLP-1s Cannot commit to long-term treatment costs and requirements Then other pathways - in-person obesity medicine, bariatric surgery evaluation, or continued lifestyle-based approaches with professional support - may serve you better